Roche to Launch Coronavirus Antigen Test
October 13 2020 - 1:50AM
Dow Jones News
By Cecilia Butini
Roche Holding AG said Tuesday that it plans to launch a
high-volume antigen test to diagnose Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) infections.
The test, which has been named Elecsys, is an automated
laboratory assay for the detection of a coronavirus antigen, the
company said.
It is performed by healthcare professionals via a nasopharyngeal
or oropharyngeal swab in patients who show symptoms compatible with
a coronavirus infection.
Roche added that the fully automated system on which Elecsys
runs can provide test results in 18 minutes for a single test,
excluding time for sample collection, transport and
preparation.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
October 13, 2020 01:35 ET (05:35 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
